Concomitant Overexpression of Cyclooxygenase-2 in HER-2–Positive on Smad4-Reduced Human Gastric Carcinomas Is Associated with a Poor Patient Outcome
Open Access
- 15 October 2004
- journal article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 10 (20) , 6938-6945
Abstract
Purpose: The expression of cyclooxygenase-2 (COX-2) is known to be involved in gastric carcinogenesis and tumor progression, but little is known about the mechanisms responsible for the up-regulation of COX-2. We examined the involvement of two growth factor-signaling systems, HER-2 and transforming growth factor (TGF)-β, in the induction of COX-2 in human gastric cancer tissue. Experimental Design: COX-2 expression was detected by immunohistochemistry in surgical specimens obtained from 166 patients with advanced gastric cancer; possible correlations between the expression of COX-2 and the expression of HER-2, TGF-β1, and Smad4, an intracellular mediator that transmits the TGF-β signal, were then analyzed. Results: COX-2 protein was overexpressed in 91 (54.8%) tumors; COX-2 overexpression was correlated with a differentiated histologic type, deep invasion, and positive lymph node metastasis. COX-2 was frequently overexpressed in HER-2–positive tumors (19 of 22, 86.4%) and in Smad4-reduced tumors (67 of 104, 64.4%) but irrelevant to the TGF-β1 expression status. The expression levels of COX-2 and HER-2 and the reduction in Smad4 were all associated with a poor patient outcome. A multivariate analysis demonstrated a significantly poor outcome for the concomitant overexpression of COX-2 in patients with Smad4-reduced tumors. Conclusions: These results support the possibility that signal transduction via HER-2 and the TGF-β/Smad system may be implicated in COX-2 expression and that the reduction of Smad4 may be, in part, of causal significance in the TGF-β-initiated overexpression of COX-2, which is associated with a poor prognosis for patients with gastric cancer.Keywords
This publication has 35 references indexed in Scilit:
- Expression of cyclooxygenase‐2 in primary and remnant gastric carcinoma: Comparing it with p53 accumulation, Helicobacter pylori infection, and vascular endothelial growth factor expressionJournal of Surgical Oncology, 2002
- Cyclooxygenase-2 Is Overexpressed in HER-2/neu-positive Breast CancerJournal of Biological Chemistry, 2002
- Induction of Cyclooxygenase-2 and Invasiveness by Transforming Growth Factor-β1 in Immortalized Mouse Colonocytes Expressing Oncogenic RasJournal of Gastrointestinal Surgery, 2002
- Japanese Classification of Gastric Carcinoma - 2nd English Edition - Response assessment of chemotherapy and radiotherapy for gastric carcinoma: clinical criteriaGastric Cancer, 2001
- Coordinate regulation of cyclooxygenase-2 and TGF-1 in replication error-positive colon cancer and azoxymethane-induced rat colonic tumorsCarcinogenesis, 1999
- Transformation of intestinal epithelial cells by chronic TGF-β1 treatment results in downregulation of the type II TGF-β receptor and induction of cyclooxygenase-2Oncogene, 1999
- Regulation of Cyclooxygenase-2 pathway by HER2 receptorOncogene, 1999
- Partnership between DPC4 and SMAD proteins in TGF-β signalling pathwaysNature, 1996
- Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2Cell, 1995
- Signal transduction by receptors with tyrosine kinase activityCell, 1990